Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
08/2012
08/29/2012CN1930293B Transgenic plants with reduced level of saturated fatty acid and methods for making them
08/29/2012CN102649810A Camptothecin derivative and preparation method and application thereof
08/29/2012CN102020698B Hepatitis c virus protease inhibitor
08/29/2012CN101429232B Hcv protease inhibitors
08/29/2012CN101426807B Neuroprotective compounds and uses thereof
08/28/2012US8252923 Peptidomimetic protease inhibitors
08/28/2012US8252904 Glycodelin monoclonal antibodies and methods for their use in the detection of ovarian cancer
08/28/2012US8252896 Process for making bivalirudin
08/28/2012US8252893 CD8 T cell epitopes in HPV 16 E6 and E7 proteins and uses thereof
08/28/2012CA2657476C Protein-binding methotrexate derivatives and medicaments containing the same
08/28/2012CA2639700C New addition salts of angiotensin-converting enzyme inhibitors with no donor acids, a process for their preparation and pharmaceutical compositions containing them
08/23/2012WO2012111438A1 Material for tissue regeneration, aqueous protein solution containing same, and method for gelling same
08/23/2012WO2012110249A1 Haprolid and derivatives thereof as inhibitors of hcv
08/23/2012WO2012109735A1 Methods of preparing cyclic amino acid molecules using arylboronic or arylborinic acid catalysts
08/23/2012US20120214732 Inhibitors of the Trypsin-Like Site of the Proteasome and Methods of Use Thereof
08/23/2012US20120213790 Methods of treatment using il-16 antagonist peptides
08/22/2012EP2489669A1 Haprolid and derivatives thereof as inhibitors of HCV
08/22/2012EP1773869B1 Macrocyclic modulators of the ghrelin receptor
08/22/2012CN102648208A Tubulin inhibitors
08/22/2012CN102643639A Force-induced fluorescence discolor materials with property of multiple colors change and preparation method and application thereof
08/22/2012CN102643329A Functional epitopes of ricin, monoclonal antibodies specifically bound with functional epitopes and use thereof in preparation of medicaments for preventing or treating ricin poisoning
08/22/2012CN102643328A Nucleoside peptide derivative for agricultural toxicity prevention and preparation method for same
08/22/2012CN101967113B 3-alloc amido-3-(3- nitryl-4-fluorophenyl) propionic acid and preparation method thereof
08/22/2012CN101962349B 3-Boc amidocyanogen-3-(3-nitryl-4-fluorophenyl) monoprop and preparation method thereof
08/21/2012US8247534 Synthesis of radiofluorinated peptide using microwave activation technology
08/21/2012US8247381 Branched water-soluble polymers and their conjugates
08/21/2012US8247379 Tumor associated amino acids and uses therefor
08/21/2012US8247193 Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester
08/21/2012CA2552319C Hcv ns-3 serine protease inhibitors
08/16/2012WO2012109167A1 Immunogenic composition comprising alpha-hemolysin oligopeptides
08/16/2012WO2012108408A1 Method for producing dipeptide and tripeptide
08/16/2012WO2012107244A1 Peptide for use in the treatment of skin conditions
08/16/2012WO2012107153A1 Amino statin derivativesfor the treatment of arthrosis
08/16/2012WO2012061082A3 Chromobacterium bioactive compositions and metabolites
08/16/2012US20120208784 Substituted propane phosphinic acid derivatives
08/16/2012US20120208771 Synthetic cholesterylamine-linker derivatives for agent delivery into cells
08/16/2012US20120208747 Novel peptide for augmenting and expression of bdnf and pharmaceutical composition for prevention and treatment of neurodegenerative diseases including alzheimer's disease or parkinson's disease, comprising the same
08/16/2012CA2826622A1 Aminostatin derivatives for the treatment of arthrosis
08/16/2012CA2826013A1 Peptide for use in the treatment of skin conditions
08/16/2012CA2825770A1 Immunogenic composition comprising alpha-hemolysin oligopeptides
08/15/2012EP2485749A1 Methods for the prevention or treatment of heart failure
08/15/2012EP2212334B1 Proteasome inhibitors
08/15/2012EP1648922B3 Spatially-defined macrocyclic compounds useful for drug discovery
08/15/2012CN102639492A Enantio- and stereo-specific syntheses of beta-amino-alpha- hydroxy amides
08/15/2012CN101845080B Angiotensin converting enzyme inhibitory peptide and preparation method thereof
08/15/2012CN101591377B Aminoacyl-phenylalanyl-tryptophan or derivative, synthetic method and application thereof
08/14/2012US8242239 MHC molecule-binding tumor-associated peptides
08/14/2012US8242238 Surface protein (HBsAg) variant of the hepatitis B virus
08/14/2012US8241856 Using filaggrin concentration in bodily fluids to diagnose arthritic disorders; immunoassay
08/09/2012WO2012104500A1 Novel peptides involved in the scf c-kit signalling pathway and compositions comprising same
08/09/2012US20120202983 Conjugates and Compositions for Cellular Delivery
08/09/2012US20120202970 Fragment Ligated Inhibitors Selective for the Polo Box Domain of PLK1
08/09/2012US20120202750 Inhibitors of iap
08/09/2012DE10113776B4 Isoliertes streptavidinbindendes, kompetitiv eluierbares Peptid, dieses umfassendes Fusionspeptid, dafür codierende Nukleinsäure, Expressionsvektor, Verfahren zur Herstellung eines rekombinanten Fusionsproteins und Verfahren zum Nachweis und/oder zur Gewinnung des Fusionsproteins An isolated streptavidinbindendes competitively elutable peptide, this complete fusion peptide, nucleic acid coding therefor, expression vector, to methods for producing a recombinant fusion protein, and methods for the detection and / or for the recovery of the fusion protein
08/08/2012EP2484688A1 Peptide epoxyketones for proteasome inhibition
08/08/2012EP2483290A1 Cyclic peptide inhibitors of hepatitis c virus replication
08/08/2012EP2483273A1 Novel macrocyclic inhibitors of hepatitis c virus replication
08/08/2012EP1828386B1 Amide and peptide derivatives of dialkylenetriamines and their use as transfection agents
08/08/2012CN102627685A Nitric oxide-donating glutathione compound, preparation method and medical purpose thereof
08/08/2012CN101967182B Antimicrobial compound and preparation method and application thereof
08/07/2012US8236807 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
08/07/2012US8236774 Human telomerase catalytic subunit
08/07/2012US8236762 Peptide-cytotoxic conjugates
08/07/2012US8236756 Prodrugs cleavable by CD26
08/07/2012CA2524258C Carrier complexes comprising cationic peptides for delivering molecules to cells
08/02/2012WO2012102308A1 Therapeutic agent and preventive agent for diabetes
08/02/2012WO2012076985A3 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
08/02/2012US20120196793 Biomarkers for iap inhibitor compounds
08/02/2012US20120196792 Macrocyclic hepatitis c serine protease inhibitors
08/02/2012US20120196789 Peptide based peroxidase inhibitors and methods of using same
08/02/2012CA2825157A1 Therapeutic or preventive agent for diabetes
08/01/2012EP2481427A1 Folate-Tubulysin conjugates
08/01/2012EP2481416A1 Eye drops
08/01/2012EP1405852B1 Diamine derivatives
08/01/2012CN102617708A T-cell death-inducing epitopes
08/01/2012CN102617706A Methods for preventing mitochondrial permeability transition
08/01/2012CN102617705A Macrocyclic compound for suppressing replication of hepatitis c viruses
08/01/2012CN102617704A Method for preparing lisinopril intermediate
07/2012
07/31/2012CA2478409C Inhibitors of urokinase, their preparation and use
07/31/2012CA2293736C Synthetic antibiotics
07/31/2012CA2223402C Methods of inhibiting phagocytosis
07/26/2012WO2012098546A2 Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
07/26/2012WO2012098439A1 Self assembly of naphthalene diimide derivatives and process thereof
07/26/2012US20120190816 Asymmetric synthesis of peptides
07/26/2012US20120190814 Thiol Protecting Group
07/26/2012US20120190614 Hcv protease inhibitors and uses thereof
07/26/2012CA2825273A1 Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
07/25/2012EP2478001A2 Advantageous mu-opiate receptor peptide compounds
07/25/2012EP2477980A1 Hcv protease inhibitors
07/25/2012EP1691814B1 Anti-inflammatory agents
07/25/2012CN102612373A Therapeutic agent for gastrointestinal diseases
07/25/2012CN102603868A Synthetic polypeptide and application of synthetic polypeptide
07/25/2012CN102603867A Polyoxin-nikkomycin hybrid antibiotic and preparation method thereof
07/25/2012CN102603866A Oligopeptide-based pH-sensitive amphoteric ion and application thereof in medicament
07/25/2012CN102603865A Dipeptide derivative and application of the dipeptide derivative
07/25/2012CN102603864A Synthesis and gel property of dendritic gel factor taking phenylalanine and glycine as construction units
07/25/2012CN101824071B Antioxidant peptide from collagen and application thereof
07/25/2012CN101747411B Aminoacyl tryptophyl tryptophan tripeptide benzyl ester as well as preparation method and application thereof
07/25/2012CN101724017B 4-nitro-L-phenylalanine dipeptide derivatives as well as preparation method and applications thereof
07/25/2012CN101519429B Solid phase method for synchronizing Argatroban
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 307